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Abstract
Background: Age-related macular degeneration (AMD) is a leading cause of legal blindness in the elderly in the
industrialized word. While the immune system in the retina is likely to be important in AMD pathogenesis, the cell biology
underlying the disease is incompletely understood. Clinical and basic science studies have implicated alterations in the
retinal pigment epithelium (RPE) layer as a locus of early change. Also, retinal microglia, the resident immune cells of the
retina, have been observed to translocate from their normal position in the inner retina to accumulate in the subretinal
space close to the RPE layer in AMD eyes and in animal models of AMD.
Methodology/Principal Findings: In this study, we examined the effects of retinal microglia on RPE cells using 1) an in vitro
model where activated retinal microglia are co-cultured with primary RPE cells, and 2) an in vivo mouse model where retinal
microglia are transplanted into the subretinal space. We found that retinal microglia induced in RPE cells 1) changes in RPE
structure and distribution, 2) increased expression and secretion of pro-inflammatory, chemotactic, and pro-angiogenic
molecules, and 3) increased extent of in vivo choroidal neovascularization in the subretinal space.
Conclusions/Significance: These findings share similarities with important pathological features found in AMD and suggest
the relevance of microglia-RPE interactions in AMD pathogenesis. We speculate that the migration of retinal microglia into
the subretinal space in early stages of the disease induces significant changes in RPE cells that perpetuate further microglial
accumulation, increase inflammation in the outer retina, and fosters an environment conducive for the formation of
neovascular changes responsible for much of vision loss in advanced AMD.
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Introduction
Age-related macular degeneration (AMD) is the leading cause of
legal blindness and visual disability for individuals aged 60 and
over in the Western hemisphere[1–4]. While the pathogenesis of
AMD is still unknown, multiple early disease alterations have been
noted to involve the retinal pigment epithelium (RPE) monolayer,
a highly specialized layer of epithelial cells essential for supporting
photoreceptors and maintaining the outer blood retina barrier [5].
In early and intermediate stages of AMD, lipoproteinaceous
deposits called drusen collect beneath the RPE layer [6]. In
addition, RPE cells develop changes in structure and distribution
that are evident as patchy hyper- and hypopigmentary changes in
the fundus (so-called ‘‘pigment mottling’’)on clinical examination
[7], and also as RPE depigmentation, hypertrophy, hyperplasia,
and atrophy, as seen on histopathological examination [8]. As
AMD progresses, choroidal neovascularization (CNV) (or ‘‘wet’’
AMD) can arise when new blood vessels from the choroid invade
the basement membrane of the RPE layer, the Bruch’s membrane,
and extend into the outer retina, with ensuing photoreceptor cell
atrophy and vision loss [9]. While early structural changes in the
RPE layer are often considered a harbinger of AMD disease
progression [10], the initiating cellular and molecular factors
inducing pathogenetic alterations in the RPE are incompletely
understood.
The role of inflammation has been prominently implicated in
the pathogenesis of AMD [11,12]. The subretinal space, the
interface between the apical surface of the RPE and the outer
segments of photoreceptors, is a locus of particular interest in the
relationship between inflammation and AMD. Under normal
conditions, the subretinal space is a zone of special immune
privilege[13], maintained by the activity of RPE cells which secrete
immunosuppressive factors into this space[14], and also by the
notable absence of retinal microglia, which perform dynamic
immune surveillance in the inner retina, but are largely excluded
from the outer retina [15]. However, under conditions of
advanced age and photoreceptor injury, retinal microglia
translocate into the outer retina [16], accumulate in the subretinal
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Significantly, activated microglia have also been found in the
subretinal space of patients with AMD [19], and are juxtaposed in
close proximity with RPE cells overlying drusen (Wong and Fariss,
unpublished data). Additionally, in a number of mouse models for
AMD, involving the absence of chemokine ligands/receptors,
CCL2 and/or CX3CR1 [20,21], microglia accumulation in the
subretinal space was accelerated and more pronounced. This
accumulation of subretinal microglia was in turn associated with
multiple features reminiscent of AMD histopathology including
the accumulation of drusen-like deposits, local RPE structural
changes, and CNV formation [20,21].
The anatomical separation between retinal microglia and RPE
cells under normal conditions and their juxtaposition into direct
and intimate contact in the subretinal space under pathological
situations suggest that cellular interactions between these two
retinal cell types may be of particular pathogenetic significance.
Microglia, serving as resident immune cells of the retina, can have
multiple functional states and carry out diverse functions [22].
Capable of rapid dynamism and motility, they also synthesize and
release multiple cytokines, chemokines, neurotrophic factors, and
neurotransmitters that allow them to interact with multiple CNS
cell types and exert cytotoxic or cytoprotective effects depending
on the tissue context [23]. While there has been evidence that
retinal microglia may interact with signals from retinal neurons
[24], photoreceptors [25], and retinal vessels [26,27], the direct
influences of retinal microglia on RPE structure, physiology, and
gene expression have not been previously addressed. An
understanding of the nature of this cell-cell interaction has the
potential to shed useful light on the cellular basis of the
inflammatory etiology of AMD.
In this study, we examined the nature of microglia-induced
effects on RPE cells using an in vitro co-culture model where
cultured activated mouse retinal microglia were co-cultured with
primary RPE cells from animals of the same genetic background.
We examined the consequences of microglial co-culture on RPE
structure, physiology, and the expression and secretion of
molecules important in influencing the inflammatory and
angiogenic environment in the subretinal space. In addition, we
employed an in vivo model of microglia-RPE interactions by
transplanting cultured microglia into the subretinal space of
experimental mice. Our results show that signals from activated
retinal microglia prominently alter the structure, properties, and
gene expression of RPE cells both in vitro and in vivo. These
alterations constitute a disorganization of the RPE monolayer and
create a pro-inflammatory environment in the subretinal space
conducive for the further recruitment of retinal microglia and for
the formation of CNV. The similarities between these alterations
and the important clinical features found in AMD strongly suggest
that microglia-RPE interactions play an important and determin-
ing role in the pathogenesis of AMD. Microglia-RPE interactions
may represent a potential locus of therapeutic intervention in the
treatment and prevention of vision loss in AMD.
Methods
Culture of Mouse Retinal Microglia Cells
All animals were handled in strict accordance with good animal
practice as defined by the relevant national and/or local animal
welfare bodies, and all animal work was approved by the NEI
Institutional Animal Care and Use Committee. Experimental
animals were housed and bred in National Institutes of Health
animal facilities. Microglia were isolated from retinas of young
C57BL/6 mice (postnatal day (P)10–30) using a method modified
from Roque and Caldwell [28]. Wild-type C57BL/6 mice, as well
as transgenic mice in which one copy of the CX3CR1 gene has
been replaced by the gene coding for green fluorescent protein
(CX3CR1
+/GFP, strain B6.129
Cx3cr1tm1/litt/J, obtained from
Jackson Labs, Bar Harbor, ME) [29], were used.
Briefly, experimental animals were euthanized and their eyes
enucleated. The globes were dissected free of periocular
connective tissue, rinsed with HBSS buffer, transferred into 2%
dispase (Roche, Nutley, NJ) in HBSS, and placed in an incubator
at 37uC for 45–60 minutes. Dispase activity was terminated by
washing the globes three times in DMEM (high glucose and L-
glutamine) plus 10% FBS (Gibco/Invitrogen, Carlsbad, CA). The
anterior segment and vitreous were excised, and the retina
dissected free from the underlying RPE layer. RPE-sclerochor-
oidal eyecups were set aside for the primary culture of RPE cells.
The retinas were transferred into culture medium consisting of
DMEM with high glucose, 10% FBS, 1x MEM non-essential
amino acids solution (Sigma, St Louis, MO), and subsequently
triturated several times with a transfer pipette. The dissociated
cells were transferred into 75 cm
2 flasks and left to grow in a 37uC
incubator. After the mixed culture had grown confluent, microglia
were found distributed on the top of the cell layer and could be
detached by shaking the flask by hand. The detached cells,
composed of 95% microglia, were then cultured in 150 mm dishes
at low density in the same culture medium. Each microglia cell,
separated from its neighbors at low culture densities, divided over
the next 2–3 weeks to form a cluster of adherent cells. Individual
cell clusters comprised solely of microglia (identifiable by their
branching morphology and their GFP-positivity when isolated
from CX3CR1
+/GFP retinas) were picked off the culture dish with
a sterile pipette and cultured in a new 25 mm
2 flask. The purity of
microglia in this resulting culture exceeded .98% and these
cultures were used in subsequent co-culture and in vivo transplan-
tation experiments.
Primary Culture of Mouse RPE Cells
Isolated RPE-sclerochoroidal eyecups from young adult C57Bl6
mice were obtained as described above. The loosely adherent RPE
cell layer was gently peeled off each eyecup using fine forceps,
transferred to a 15 ml tube containing culture medium comprised
of Medium199, 15% FBS (Gibco, Carlsbad, CA) and 1x MEM
with non-essential amino acids (Sigma, St. Louis), and then
triturated with a transfer pipette to form a dissociated cell
suspension. This suspension was plated on a serum pretreated 6-
well plate. RPE cells from a total of 10–12 eyes were used per 6-
well plate. The medium was changed after 7 days, and every 2–3
days thereafter. The RPE cells grew to form a confluent cell layer
by 2–3 weeks and were used in co-culture experiments at that
point.
Co-culture of Retinal Microglia Cells with Primary RPE
Cells
Cultured retinal microglia were collected and cultured onto
Transwell permeable support membrane inserts (Corning, Corn-
ing, NY) and grown to 60–70% confluence. The microglial
cultures were first incubated in DMEM with 5% heat-inactivated
serum for 24 hrs, then activated by the addition of lipopolysac-
charide (LPS) (1 mg/ml, Sigma) for 6 hrs, and subsequently
washed well 3 times in HBSS to remove all traces of LPS.
Separately, RPE cultures were grown to confluence in a 6-well
plate (density of 1-5610
6 cells/well), washed 3 times with HBSS,
and then placed in 0.5 ml of DMEM with 5% heat-inactivated
serum. The previously prepared Transwell inserts containing
either untreated or LPS-treated retinal microglia were then placed
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inactivated serum. Control RPE cultures were incubated with
empty inserts without cultured microglia. RPE-microglia co-
cultures and controls were kept in a 37uC incubator in 5% CO2
for 24 hours. At the end of this period, the inserts were removed,
and the supernatant overlying the RPE cells collected. The RPE
cells in the well were washed twice with PBS and then
homogenized for mRNA or protein analysis. At least 3 co-culture
repeats were performed for all analyses.
Immunohistochemistry
Cultured cells and retinal tissue for immunohistochemical
analyses were fixed (30 minutes for cultured cells and 4 hours
for retinal tissue) in 4% paraformaldehyde in PBS, washed with
phosphate buffered saline containing 0.25% Tween 20 (PBST),
and then permeabilized with Triton-X (0.25% for cultured cells,
1% for tissues)(Sigma, St. Louis, MO) for 30 minutes. Cells or
tissues were placed in a blocking solution (USB, Rodeo Blocker,
Cleveland, OH) for 30 minutes, and incubated overnight with
primary antibodies to the following antigens: CD11b, 1:200; F4/
80, 1:200; CD68, 1:200 (all from AbD Serotec, Raleigh, NC);
ionized calcium binding adaptor molecule-1 (Iba1), 1:500 (Wako,
Richmond, VA); GFAP, 1:200; Alexa Fluor 633-conjugated
Phalloidin, 1:100; zonula-occludins-1 (ZO-1), 1:200 (all from
Invitrogen, Carlsbad, CA); NeuN, 1:200 (Millipore, Billerica, MA);
vimentin, 1:200 (MP Biomedicals, Solon, OH); CD31 [P2B1],
1:100 (Development Studies Hybridoma Bank, Iowa City, IO).
After washing, secondary antibodies, which were conjugated to
either Alexa-488 or Alexa-568 (Invitrogen, Carlsbad, CA), were
added at a 1:200 dilution and incubated for 1–2 hrs.
Semi-Quantitative RT-PCR
Total RNA was extracted from RPE cells with RNeasy Mini kit
(Qiagen, Valencia, CA). First-strand cDNA was synthesized with a
cDNA synthesis kit (Ambion, Austin, TX) according the
manufacturer’s protocol using oligo-dT as the primer. PCR
amplifications were conducted in a total volume of 15 ml,
comprising of 1 ml of the cDNA, 2 ml of primer mixture, and
12 ml of Plus Master Mix (Qiagen, HotStarTaq Plus). After an
initial denaturation at 95uC for 5minutes, PCR amplification was
conducted for 20–35 cycles, and GAPDH was used as an internal
control. A list of primers used is provided in Table 1. At least 3
replicates of each experiment were performed.
ELISA and Western Blotting
Following co-culture with retinal microglia, the media of the
RPE cell cultures were collected for analysis. Also, RPE cells at the
bottom of the culture wells were then washed 3 times with PBS
and homogenized in 300 ml of RIPA buffer (Sigma, St. Louis)
containing a protease inhibitor cocktail (Calbiochem, Gibbstown,
NJ). The cell lysate was transferred into a 1.5 ml eppendorf tube,
Table 1. DNA primers used for RT-PCR.
Oligos Forward (59-3 9) Reverse (59-3 9) Tm(uC) Length(bps)
Claudin1 gcagctgctgggtttcatc gtctttcccactagaaggtg 56 610
CRALBP gagtggttatgctcttcaacatc cataaggctgtgttctcaacttc 56 467
CX3CL1 ttcacgttcggtctggtggg ggttcctagtggagctaggg 60 970
GAPDH cctctggaaagctgtggcg gttgctgtagccgtattcatt 56 404
GM-CSF gtggctgcagaatttacttttc ggactggttttttgcattcaaa 56 416
ICAM1 ctgaccctgagccagctgg ggcctcctcctgagccttc 56 633
IFN-c ctggtggttgctcctcttac ctcctgggcctctcctgtg 56 674
IL10 ggctcagcactgctatgct gatcatcatgtatgcttctatg 56 516
IL1-b gccaccttttgacagtgatgag ttaggaagacacagattccatg 56 778
IL6 atgaagttcctctctgcaagag ctaggtttgccgagtagatctc 56 636
MCP1 gcaggtccctgtcatgctt ctagttcactgtcacactgg 56 445
MMP1a ggtaaatagattcatgccagaac ccatgtactagaatcacggg 56 478
MMP1b ggttctacattcgggtaattagc cactggaatcatcaattcttcttg 56 477
MMP2 ggaccctggagctctgatg ccagccagtctgatttgatgc 56 737
MMP9 cctcacctggccccacaag ctgcaggaggtcgtaggtc 56 713
Occludin ctgactatgcggaaagagttg ccgtctgtcataatctcccac 56 626
OTX2 ccgccaacagcagcagcag cctggaatttccatgaggac 56 584
PEDF ccagtgccctcagcatcctt ccaggattctgcctatgaagag 56 642
Rantes gaagatctctgcagctgccc ctagctcatctccaaatagttg 56 274
RPE65 gccaatttacgtgagaattggg cagtccatggaaggtcacag 56 558
SDF-1a ggacgccaaggtcgtcgc cttgtttaaagctttctccagg 56 265
TGFb ccactgatacgcctgagtg gctgcacttgcaggagcg 56 605
TNFa atgagcacagaaagcatgatc tcacagagcaatgactccaaag 56 678
VCAM1 ggataccagctcccaaaatcc cactttggatttctgtgcctc 56 605
VEGF ctactgccgtccgattgagac ggcttgtcacatctgcaagtac 56 417
ZO1 gctcatagttcaacacagcctc ggtcaatcaggacagaaacaca 56 511
doi:10.1371/journal.pone.0007945.t001
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16,000 rpm. The clarified RPE cell lysates were then analyzed by
Western blotting and ELISA. The overall protein level in both
RPE lysates and RPE co-culture media were measured with BCA
Protein Assay kit (Pierce, Rockford, IL). Pigment epithelium-
derived factor (PEDF) and CX3CL1 protein levels were measured
with ELISA kits (BioProducts MD, Middletown, MD and R&D
Systems, Minneapolis, MN) according to the manufacturers’
instructions. The levels of MMP1 protein were evaluated by
Western blotting. The levels of all other proteins were assayed with
a commercial chemiluminscence-based ELISA (Searchlight,
Aushon Biosystems, Billerica, MA). At least 3 replicates of each
experiment were performed.
Western blots for MMP1 were performed by first diluting the
samples 1:5 with PBS, and loading 15 ml of the solution on a
NuPAGE 4–12% Bis-Tris gel (Invitrogen). Following electropho-
resis, proteins in the gel were transferred onto nitrocellulose
membranes (iBlot Gel Transfer Stacks, Invitrogen). After blocking
overnight with a buffer containing 3%BSA and 5% blocking
reagent (Rodeo Blocker, USB), the blot was incubated with the
primary antibodies for MMP1 (1:1000) (Abbiotec, San Diego, CA)
or b-actin (1:2000) (Santa Cruz Biotechnology, Santa Cruz, CA)
for 1 hr. Anti-rabbit-HRP (IVD Research, Carlsbad, CA) or anti-
goat HRP (Santa Cruz Biotechnology) were used as secondary
antibodies (1:3000, 1 hr). Resulting blots were developed using
chemiluminescent detection (Amersham Hyperfilm ECL, GE
Healthcare, Piscataway, NJ) and protein expression levels
quantitated using image analysis software (ImageQuant, GE
Healthcare).
RPE Apoptosis and Proliferation Assays
RPE cells from co-culture experiments and their controls were
fixed with 4% paraformaldehyde in PBS for 30 minutes and
incubated in 0.25% Triton X-100 for 30 minutes. Apoptotic cells
were labeled using a TUNEL assay kit according to the
manufacturer’s instructions (Roche, Nutley, NJ), imaged using
an epifluorescence microscopy, and counted. Quantification of
BrdU labeling was used to measure RPE proliferation. BrdU was
added to the cultures to a concentration of 10 mM and incubated
for 2.5 hours after which the cells were fixed in 4% paraformal-
dehyde in PBS. Proliferating cells were stained with an anti-BrdU
antibody overnight (G3G4, 1:200, Developmental Studies Hy-
bridoma Bank, Iowa City, IA), followed by an anti-mouse
secondary Alexa-568 antibody (Invitrogen), and BrdU+ cells
counted in representative 10x fields.
Angiogenesis Assays
Primary endothelial cell proliferation was measured using a
BrdU labeling method. Endothelial cells from mouse aorta were
grown at low density in collagen-coated chambers in experimental
and control co-culture RPE supernatants for 3 days. BrdU was
added to the cultures to a concentration of 10 mM and incubated
for 2.5 hours, after which the cells were placed in 4%
paraformaldehyde in PBS for 30 min, 0.5% triton X-100 for
30 min, 1:1 solution of PBST and 4N HCl for 1 hr, and then a 2%
blocking agent for 30 min. Labeling and quantification of
proliferating cells were performed as described earlier for RPE
cultures.
In vitro endothelial cell proliferation and migration were also
assessed using the scratch wound healing assay [30]. Briefly,
primary mouse aortic endothelial cells were grown to confluence
on 6-well tissue culture plates whereupon a scratch wound of
uniform width was made with a sterile 200-ml pipette tip through
the center of the well. After wounding, the cultures were washed 3
times with serum-free DMEM medium. One ml of conditioned
medium from experimental and control co-cultures were then
added to each well. The cells in each well fixed and stained with
CD31 and DAPI at 0 and 16 hr post-wounding, photographed
with an inverted microscope, and the width of the scratch wound
(mean of 6 measurements per scratch wound) measured. At least 9
scratch assays were performed per condition.
Sprouting angiogenesis in an organ culture model was
performed using the aortic ring assay. As described previously
[31], thoracic aortas were excised from 4-week old mice, flushed
with media to remove the clotted blood inside, and the
periadventitial fibroadipose tissue trimmed away. Excised aortas
were inverted to expose the vascular endothelium, cut into small
cross-sectional pieces approximately 1 mm long, and placed into a
well of a 8-chamber slide (Lab-Tek
TM, NUNC, Rochester, NY)
that had been pre-coated with a 0.1 mg/ml collagen solution
(Stemcell Technologies, Vancouver, BC, Canada). The aortic
rings were incubated in either experimental or control co-culture
supernatants for 48 hrs at 37uC and 5% CO2. Endothelial
outgrowths of the cultured rings were photographed and the
number of cell nuclei counted. At least 6 replicates were used in
each group.
Microglial Chemotaxis Assay
Microglial chemotaxis was evaluated using 48-well Boyden
chemotaxis chambers (Neuroprobe, Gaithersburg, MD) [32]. A
5 mm polycarbonate filter (Neuroprobe, Gaithersburg, MD)
separated the top and bottom chamber compartments. Cultured
retinal microglia cells growing in a culture flask were harvested
with 0.25% trypsin-EDTA, neutralized with 10% serum in
DMEM medium, washed 3 times with serum-free DMEM
medium, and resuspended in DMEM plus 5% heat inactivated
serum to a concentration of 1-2610
5 cells/ml. A volume of
50 ml of resuspended cells was added to the top chamber and a
volume of 50 ml of experimental or control medium was added
to bottom chamber. The chamber assembly was then incubated
for 2 hrs at 37uC. On disassembly of the chamber, the
membrane filter was wiped off carefully to remove adherent
cells on the top of the filter, fixed in 4% paraformaldehyde for
30 min, and then washed 3 times with PBS. Cells migrating to
the bottom of the filter were stained with DAPI (Vector Labs,
B u r l i n g a m e ,C A ) ,p h o t o g r a p h e dw i t ha ne p i f l u o r e s c e n c e
microscope, and counted.
Subretinal Injection of Retinal Microglia
Experimental animals were anesthetized by the intraperitoneal
injection of ketamine (90 mg/kg) and xylazine (8 mg/kg). As
described in Zhao et al.[33], the sclera was exposed on the
temporal side of the globe and a small incision made with a sharp
33-gauge needle between the limbus and the equator to gain
access to the subretinal space. Cultured microglia, previously been
activated with LPS (1 mg/ml) for 6 hrs, and then washed 3 times in
HBSS, were resuspended in DMEM medium at a density of
1610
8/ml. This suspension was then added to growth factor-
reduced Matrigel (BD Biosciences, Bedford, MA) at a 1:1 volume
ratio and 1.5 ml of the resulting mixture was slowly injected
through the scleral incision into the subretinal space using a blunt
needle attached to a Hamilton micro-syringe. The injection was
gradually introduced allowing the gel mixture to dissect smoothly
into the subretinal space, forming a circular bleb posterior to the
injection site. Control injections of a similar volume of Matrigel
and DMEM medium (without microglia) were made into the
subretinal space of the contralateral eye.
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Experimental animals were euthanized with CO2 inhalation
and perfused intracardiacally with 4–5 mls of PBS, followed by 4–
5 mls of a 160 mM solution of 1, 1’-Dioctadecyi-3, 3, 39,3 9-
tetramethylindocarbocyanine perchlorate (DiI, Sigma-Aldrich, St.
Louis, MO), and then finally with 20 mls of 4% paraformaldehyde
(in 0.1 M phosphate buffer, pH 7.4), as previously described [34].
Eyes were harvested and sclerochoroidal whole-mounts of entire
posterior segments prepared. The injection entry site and the area
covered by the subretinal Matrigel-cell mixture were located on
the whole-mounted tissue, photographed with an epifluorescence
microscope and/or confocal microscopy (SP2; Leica, Exton, PA),
and quantified using computer-assisted software (NIH Image J).
Statistical Analysis
Statistical analyses were performed using GraphPad Prism
Software (La Jolla, CA). Unpaired t-tests or analysis of variance
(ANOVA) were used to determine whether differences existed
between experimental mean values. A P value,0.05 was
considered significant.
Results
Culture of Mouse Microglia Cells
Our procedure for isolating microglia in culture resulted in a
population of cells that are highly enriched in retinal microglia.
Almost all (.98%) of the DAPI-positive cells isolated from
CX3CR1
+/GFP transgenic mice were also GFP-positive, indicating
the expression of CX3CR1, a specific marker of microglia and
dendritic cells in the retina [15] and the brain [35] (Fig. 1A). These
GFP+ cells were also immunoreactive for markers positive in
microglia including ionized calcium-binding adapter molecule-1
(Iba-1) (Fig. 1B), CD11b (Fig. 1C), F4/80 (Fig. 1D), and CD68
(Fig. 1E). Cultured cells were immunonegative for macroglial
markers, such as glial fibrillary acidic protein (GFAP) (Fig. 1F) and
vimentin (Fig. 1G), and for neural markers such as NeuN (Fig. 1H)
and neurofilament-associated antigen, 3A10 (data not shown).
These findings indicate the predominance of microglia cells in the
culture with a relative absence of contaminating glial and neuronal
cells.
Co-culture with Retinal Microglia Induces Structural and
Proliferative Changes in Primary RPE Cells
In order to investigate the effects of activated retinal microglia
on RPE cells, we employed an in vitro system in which primary
mouse RPE cells are grown to confluence in culture and then co-
cultured with mouse retinal microglia cells (RMG) isolated from
animals of the same genetic background. Retinal microglia were
activated by exposure to LPS (1 mg/ml for 6 hrs), washed
extensively with media, and then co-cultured with primary RPE
cells on an adjoining tissue-culture insert for 24 hrs, without
directly exposing target RPE cells to LPS. RPE cells co-cultured
with unactivated RMG and RPE cells which were unexposed to
RMG were used as controls. After co-culture, the RPE cells and
the overlying supernatant are harvested and analyzed separately.
We first investigated the effect of RMG co-culture on RPE cells
in terms of their expression of visual cycle proteins and structural
junctional proteins. RPE cells co-cultured with LPS-activated
microglia, compared to unexposed RPE cells, expressed signifi-
cantly lower levels of junctional proteins ZO-1 and claudin-1, as
well as lower amount of RPE-65 (Fig. 2A). RPE cultured with
unactivated RMG expressed significantly reduced levels of ZO-1,
but not claudin-1 and RPE65, when compared with unexposed
controls. However, mRNA levels of occludin, CRALBP, and
RPE-transcription factor, Otx2, were unchanged with microglia
co-culture. These induced alterations in gene expression in RPE
were accompanied by significant changes in the structure of the
primary RPE cells. Immunostaining for ZO-1, a protein normally
located in the tight junctions between RPE cells, revealed a
marked mislocalization of ZO-1 from a junctional distribution
seen in control cultures (Fig. 2B) to a more diffuse, cytoplasmic
pattern following microglia co-culture (Fig. 2C), suggesting a
disorganization of tight junctions. The regular hexagonal mosaic
of RPE cells was also disrupted, with individual RPE cells showing
pleomorphic morphologies and irregular distributions, indicating a
loss of proper cell-cell relationships between neighboring RPE
cells.
The effect of microglia co-culture (either with or without prior-
LPS activation) however did not result in a higher level of
apoptotic RPE cell death as demonstrated using a TUNEL assay
(Fig. 2D). Despite prominent structural disorganization, very few
RPE cells following microglia co-culture were TUNEL-positive.
Figure 1. Immunoreactivity of cultured retinal microglia from
CX3CR1
+/GFP transgenic mice. Retinal microglia isolated from
CX3CR1
+/GFP transgenic mice exhibited GFP fluorescence (A) as driven
by the microglial-specific CX3CR1 promoter. Cultured cells were
immunoreactive for classic microglial markers Iba-1 (B), CD11b (C), F4/
80 (D), and CD68(E). The cells were immunonegative for other
macroglial markers such as GFAP (F), vimentin (G), and neuronal
markers, such as NeuN (H). Scale bar=100 mm.
doi:10.1371/journal.pone.0007945.g001
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demonstrated significantly higher rates of proliferation, with
greater numbers of cells showing positivity for BrdU labeling,
relative to either unactivated microglia co-culture or unexposed
RPE cells, (Fig. 2E). In summary, exposure to activated microglia
induced RPE cells to change their expression of certain tight
junction and visual cycle proteins, to lose the integrity of tight
junctions between neighboring cells, and to increase in their
proliferation rate, that in combination is likely to have contributed
to a more disorganized and irregular RPE layer.
RPE Expression of Chemotactic Cytokines and Cell
Adhesion Molecules Is Increased Following Co-Culture
with Activated Retinal Microglia
In aged animals, microglia accumulates in the subretinal space
as a function of increasing age [16]. It is possible that microglia in
the subretinal space may induce changes that may further attract
additional microglia cells to the area. To address the question of
whether RMG-induced changes in RPE cells may result in the
further microglial recruitment, we assayed the expression of
chemotactic cytokines, CCL2 (MCP1), CCL5 (RANTES),
CX3CL1 (fractalkine), and SDF-1 (CCL12), in RPE cells that
were either co-cultured in the presence of activated RMG,
unactivated RMG, or cultured alone. We also assayed the RPE
expression levels of membrane-associated adhesion molecules,
VCAM-1 and ICAM-1, which can bind receptors on the cell
surfaces of microglia and retain them in the subretinal space. We
found that the transcription levels of CCL2, CCL5, and VCAM-1
mRNA were significantly increased after co-culture with activated
retinal microglia compared to unexposed controls (Fig. 3A). The
level of ICAM-1 mRNA was slightly but not significantly
increased. Protein levels of CCL2, CCL5, as well as SDF-1, were
also found on ELISA analysis to be elevated in both RPE cell
lysates and supernatants when co-cultured with activated RMG
(Fig. 3B, C). VCAM-1 and ICAM-1 levels were also both
increased in RPE cell lysates of these cultures. However, CX3CL1
expression in RPE cells was not altered by activated RMG co-
culture (Fig. 3A–C). In general, the levels of chemokine expression
in RPE cells co-cultured with unactivated RMG were either
similar to that in unexposed RPE controls or intermediate between
that found in unexposed controls and RPE cells co-cultured with
activated RMG (gray bars, Fig. 3A–C). Taken together, co-culture
with activated retinal microglia induced RPE cells to up-regulate
the expression and secretion of chemoattractants, CCL2, CCL5,
and SDF-1, which are capable of attracting retinal microglia into
the subretinal space, and to also increase the expression of cell-
surface adhesion molecules which may retain microglia in that
location.
Supernatants from RPE co-cultures were also assessed for their
ability to induce microglia chemotaxis using a Boyden chamber
assay. While supernatants from unexposed RPE cells did not
significantly increase the number of migrating microglia compared
to control medium (DMEM) (Fig. 3D), supernatants from RPE
cells previously co-cultured with either unactivated or activated
retinal microglia were able to significantly augment microglia
migration. This indicated that retinal microglia, independent of
their previous activation by LPS, can induce RPE cells to produce
factors effective in increasing the chemotaxis of retinal microglia as
assessed in this in vitro assay.
RPE eExpression and Secretion of Pro-Inflammatory
Cytokines Is Increased Following Co-Culture with
Activated Retinal Microglia
Previous studies have demonstrated that RPE cells are able to
express and secrete various pro-inflammatory and anti-inflamma-
tory factors, often under the influence of various cytokines [36].
We investigated here the effect of retinal microglia co-culture on
the expression of inflammatory factors and cytokines in RPE cells.
We observed that relative to controls, RPE co-cultured with
activated RMG expressed higher mRNA levels of the pro-
inflammatory factors, IL-1b, TNF-a, IL-6, and GM-CSF
(Fig. 4A). ELISA analyses also revealed that the levels of these
factors in the RPE cell lysates (Fig. 4B) and RPE supernatants
(Fig. 4C) were markedly increased. IFN-c levels were also
Figure 2. Primary RPE cells are altered in gene expression,
structure and proliferation following co-culture with retinal
microglia (RMG). (A) Quantitative RT-PCR comparing mRNA levels of
visual cycle (RPE65, CRALBP) and junctional proteins (ZO-1, Claudin-1,
Occludin) in RPE cells cultured alone (control, white bars), or co-cultured
with either unactivated RMG (gray bars) or RMG pre-activated with LPS
(black bars). Results were normalized relative to levels in unexposed RPE
cells. (B–C) ZO-1 labeling (green) in confluent primary RPE cells co-
cultured in the absence (B) and the presence of activated RMG (C). Co-
culture with RMG induced the loss of discrete localization of ZO-1 in RPE
tight junctions. Scale bar=50 mm. (D) RPE cell apoptosis, as measured
by TUNEL labeling, in the presence of conditioned media from
unexposed RPE cells (white), or from RPE cells co-cultured with
unactivated (gray), or activated RMG (black) (*p=,0.0001, n=8
replicates). (E) RPE cell proliferation, as measured by BrdU staining, in
the presence of unexposed RPE cells (white) or from RPE cells co-
cultured with unactivated RMG (gray), or activated RMG (black).
(p=0.973, n=12 replicates for each condition.) Significant differences
(p,0.05) are indicated with *.
doi:10.1371/journal.pone.0007945.g002
Microglia-RPE Interactions
PLoS ONE | www.plosone.org 6 November 2009 | Volume 4 | Issue 11 | e7945increased in the cell lysate but not in the supernatant. Conversely,
the anti-inflammatory cytokine, IL-10, which was present at low
levels in the RPE cells, was not markedly changed. Expression
levels of TGF-b, which are constitutively high in unexposed RPE
cells, did not markedly alter after co-culture with activated RMG.
In general, the levels of cytokine expression in RPE cells co-
cultured with unactivated RMG were either similar to that in
unexposed RPE controls or intermediate between that found in
unexposed controls and RPE cells co-cultured with activated
RMG (gray bars, Fig. 4A–C). Overall, the effect of co-culture with
activated microglia increased the RPE expression and secretion of
multiple pro-inflammatory cytokines, suggesting that the subret-
inal accumulation of microglia in aged animals may promote a
more pro-inflammatory environment in the subretinal space.
RPE Expression and Secretion of Pro-Angiogenic
Mediators Is Increased Following Co-Culture with
Activated Retinal Microglia
RPE expression levels of angiogenic mediators were also assessed
at the mRNA and protein levels in the presence and absence of
retinal microglia co-culture. In particular, the expression of
metalloproteinases was assessed. These included MMP1 (interstitial
collagenase), MMP2 (gelatinase A), and MMP9 (gelatinase B),
whose ability to degrade extracellular matrix components may
promote endothelial cell migration and subretinal neovasculariza-
tion. Also, expression levels of the pro-angiogenic factor, vascular
endothelial growth factor (VEGF), and the anti-angiogenic factor,
pigment epithelial growth factor (PEDF), were evaluated. Figure 5
shows that mRNA levels were increased for MMP1 and MMP9
(Fig. 5A), while protein levels of MMP1, MMP2, and MMP9, as
well as VEGF, as assessed by ELISA and Western blot analysis,
were increased in RPE cell lysates (Fig. 5B) and supernatants
(Fig. 5C) following co-culture with activated microglia. PEDF
expression and secretion levels were however relatively unchanged.
In general, the levels of angiogenic factors in RPE cells co-cultured
with unactivated microglia were either similar to that in unexposed
RPE controls or intermediate between that found in unexposed
controls and RPE cells co-cultured with activated microglia (gray
bars, Fig. 5A–C). These results indicate that activated microglia in
thesubretinal spacemayinduceexpression andsecretion changes in
RPE cells that can foster a more pro-angiogenic local environment
at the retinochoroidal junction.
Figure 3. Primary RPE cells increase expression and secretion of chemotactic cytokines and cell adhesion molecules following co-
culture with retinal microglia (RMG). (A) Quantitative RT-PCR comparing mRNA levels of chemotactic cytokines (CCL2, CCL5, CX3CR1, SDF-1),
and adhesion molecules (VCAM-1, ICAM-1) in RPE cells. Levels from RPE cells co-cultured with unactivated RMG (gray bars) or activated RMG (black
bars) were measured and normalized relative to levels from unexposed RPE cells (white bars). Levels of chemokines and adhesion molecules in the
cell lysates (B) and supernatants (C) of RPE cultures were measured with ELISA and compared. Chemotactic cytokines, CCL2, CCL5, and SDF-1, capable
of attracting microglia cells, were found at increased levels in supernatant of RPE cells co-cultured with activated RMG. These chemokines were also
slightly but non-significantly, elevated in the presence of unactivated RMG. RPE cell lysates also contained increased levels of the adhesion molecules
VCAM-1 and ICAM-1 that are able to bind and retain microglia in the subretinal space. (D) Chemotaxis of retinal microglia, as assayed using a Boyden
chemotaxis chamber, was significantly increased when incubated with supernatant from RPE cultures co-cultured with either unactivated (gray bar)
or activated RMG (black bar), when compared to that from unexposed RPE cells or to control medium (DMEM). (*p=,0.001, n=12 replicates).
Significant differences (p,0.05) are indicated with *.
doi:10.1371/journal.pone.0007945.g003
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angiogenesis was also evaluated in a number of in vitro assays.
Supernatants from RPE cells co-cultured with activated microglia,
with unactivated microglia, and from unexposed RPE cells, were
placed together with primary endothelial cells or endothelial organ
cultures and tested for their ability to affect angiogenesis.
Supernatants from activated microglia-RPE co-cultures significantly
increased primary endothelial cellproliferation relative to thosefrom
unexposed RPE cells as measured using a BrdUassay(Fig.6A).Also,
these supernatants promoted a relatively higher rate of primary
endothelial cell migration as evaluated using a scratch wound assay
(Fig. 6B). Sprouting angiogenesis as evaluated in an organ culture
(aortic ring) assay was also significantly increased in the presence of
supernatants from activated microglia co-cultures (Fig. 6C). Gener-
ally, the effects of supernatants from unactivated microglia-RPE co-
cultures were intermediate between those that induced by
supernatants from unexposed RPE cultures and activated microg-
lia-RPE co-cultures. These findings underline the ability of activated
RMG to induce RPE changes that promote angiogenesis.
Subretinal Transplantation of Retinal Microglia Promotes
Choroidal Neovascularization, RPE Disorganization, and
Microglia Recruitment
In order to evaluate how the in vivo presence of subretinal
microglia may contribute to a pro-inflammatory, pro-angiogenic
Figure 4. Primary RPE cells increase expression and secretion of
pro-inflammatory cytokines following co-culture with retinal
microglia (RMG). (A) Quantitative RT-PCR comparing mRNA levels of
pro-inflammatory factors (IL-1b, TNF-a, IL-6, IFN-c, GM-CSF) and anti-
inflammatory factors (IL-10, TGF-b) in RPE cells co-cultured with
unactivated (gray bars) and activated (black bars) RMG relative to
unexposed RPE cells (control, white bars). Results were normalized
relative to levels in unexposed RPE cells. Levels in the cell lysates (B) and
supernatants (C) of RPE cultures were also measured with ELISA and
compared. RPE expression of pro-inflammatory cytokines IL-1b,T N F - a, IL-
6, and GM-CSF were substantially elevated following culture in both cell
lysate and supernatants, reflecting a general increase in pro-inflamma-
tory mediators. Significant differences (p,0.05) are indicated with *.
doi:10.1371/journal.pone.0007945.g004
Figure 5. Primary RPE cells increase expression and secretion of
pro-angiogenic factors following co-culture with retinal microg-
lia (RMG). (A) Quantitative RT-PCR comparing mRNA levels of
metalloproteinases (MMP1, MMP2, MMP9), and growth factors, VEGF
and PEDF, in RPE cells co-cultured with unactivated (gray bars) and
activated RMG (black bars) relative to control (unexposed RPE cells, white
bars). (B)Protein analyses of RPEcell lysates showing that levelsof MMP2,
MMP9, and VEGF, as analyzed by ELISA, were increased following RMG
co-culture (left). MMP1 levels, as analyzed by Western blotting, were also
significantly elevated (right). (C) Protein analyses of RPE supernatants
showing similar significant increasesby ELISA analyses (MMP9, VEGF, left)
and by Western blotting (MMP1, right). Levels of PEDF, an anti-
angiogenic factor, were unchanged by co-culture in both RPE cell lysates
and supernatants. Significant differences (p,0.05) are indicated with *.
doi:10.1371/journal.pone.0007945.g005
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the subretinal space above the RPE layer. GFP-labeled retinal
microglia, isolated from CX3CR1
+/GFP mice, were activated with
LPS, washed extensively, placed in growth-factor reduced
Matrigel, and then injected into the subretinal space of adult
wild-type mice. Injections of growth-factor reduced Matrigel
mixed with DMEM medium (without microglia) were performed
in the contralateral eyes to serve as controls. Animals were
euthanized 4 days following subretinal injection and perfused with
DiI to label choroidal vascular structures. Analysis of RPE
flatmounts revealed that eyes with subretinally-transplanted
microglia develop large and prominent choroidal neovasculariza-
tion (CNV) membranes in the subretinal space, whereas CNV
membranes were either absent or much more rudimentary in
control injections (Figure 7A–D). The CNV membranes that
formed in treated eyes were observed to extend horizontal in a
branching manner in the subretinal space within the zone of
subretinal microglia transplantation (Fig. 7C).
RPE cells underlying the area of subretinal microglial
transplantation were also evaluated in sclerochoroidal whole-
mount preparations. Phalloidin staining for F-actin in RPE cells
revealed that while regular structure and distribution of RPE cells
were mostly preserved in control injections (Fig. 7E), the structure
of RPE cells that were in contact with injected subretinal microglia
were markedly more pleomorphic and irregularly distributed
(Fig. 7F), similar to that seen in co-cultured primary RPE cells.
Quantitative comparisions of the fractional area of the RPE layer
with abnormal RPE cell distributions also showed significant
differences between control and microglia-injected eyes (data not
shown). In addition, endogenous (i.e., non-transplanted) retinal
microglia in recipient animals were immunolabeled with Iba-1 in
order to follow changes in their distribution after transplantation.
We observed that these GFP-, Iba-1+ retinal microglia were
recruited to the outer retina at the injection site in greater numbers
than that seen in control eyes (Fig. 7G and H). These cells were
likely to have migrated from the inner retina through the outer
nuclear layer to gain access to the subretinal space where they
subsequently accumulate (Fig. 7I).
Discussion
In the present study, we found that as a consequence of coming
into close proximity with activated retinal microglia, primary RPE
cells developed multiple structural and functional alterations.
These involved decreased expression levels of visual cycle protein,
RPE65, and proteins in the tight junctions (ZO-1 and claudin-1), a
disruption of ZO-1 localization in cell junctions, and a loss of
regular RPE cell shape and distribution. Interestingly, RPE cells
co-cultured with retinal microglia did not undergo higher rates of
Figure 6. Conditioned supernatants from RPE cells co-cultured
with retinal microglia (RMG) increase angiogenesis in in vitro
models. (A) Primary endothelial cells show higher rates of proliferation
when exposed to supernatants of RPE cells co-cultured with activated
RMG (black bar) compared to supernatants from unexposed RPE cells
(white bar) (*p=0.007, unpaired t-test, n=7 replicates). Proliferation of
endothelial cells exposed to supernatants of RPE cells co-cultured with
unactivated RMG (gray bar) was slightly but not significantly elevated.
(B) Primary endothelial cell migration, as evaluated by a scratch wound
assay, was increased in the presence of culture supernatants from RPE
cells co-cultured with either unactivated (gray bar) or activated RMG
(black bar), relative to that from unexposed RPE (white bar). The assay
was scored according to the ability of endothelial cells to migrate into a
scratch wound of uniform width marked on a confluent layer of
endothelial cells (lower panels, cells stained with CD31 (red) and DAPI
(blue), n=9 replicates) (C) Sprouting angiogenesis, as evaluated by an
aortic ring assay, was increased in the presence of culture supernatant
from RPE cells co-cultured with activated RMG (black bar), compared to
that from unexposed RPE (white bar). Measurements were slightly but
non-signficantly increased with supernatants from RPE cells co-cultured
with unactivated RMG (gray bar). Endothelial cell nuclei from vessels
sprouting from sections of vascular aortic rings were scored (n.=6
replicates).
doi:10.1371/journal.pone.0007945.g006
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These changes indicate that RPE cells, under the influence of
activated microglia, may lose integrity in their cellular morphology
and intercellular contacts, proliferate in a less regulated manner,
and thus lose its original configuration as a uniformly-spaced
monolayer and form irregular cellular aggregates as seen in our in
vitro and in vivo experiments. Indeed, in eyes with early and
intermediate AMD, prior to the onset of CNV, analogous changes,
the form of RPE hypertrophy and clumping in the subretinal space
and outer retina seen may be seen on histopathological and
clinical examination [7,8]. Photoreceptor loss [8] and synaptic
pathology [37] have also been observed in AMD eyes in areas of
drusen and pigmentary alteration, which may potentially be
related to decreases in expression of RPE65 in RPE cells, inducing
dysfunctional changes in visual pigment cycling and photoreceptor
physiology [38]. Taken together, the changes induced by retinal
microglia on RPE cells in our in vitro and in vivo models bear
resemblances to aspects of RPE alterations in AMD, suggesting
that the in vivo accumulation of retinal microglia in the subretinal
space seen in AMD[19] may indeed drive relevant pathogenic
mechanisms. In the late atrophic form of AMD, RPE cells
undergo eventual atrophy in a contiguous manner in the form of
geographic atrophy [39]; while we did not observe an increase in
RPE apoptosis over the time scale of our in vitro co-culture systems,
the possibility that prolonged co-culture with retinal microglia may
result in pro-apoptotic effects cannot be ruled out.
RPE cells play an important immunomodulatory role in the outer
retina, in part by producing and secreting multiple cytokines [36]
that contribute to the environment of immune privilege in the
subretinal space [13]. RPE cells, in expressing receptors for various
cytokines [40], also respond prominently to cytokine signaling by
altering levels of cytokine production and secretion, synthesizing
nitric oxide [41], increasing adhesion molecule expression[42], and
regulating RPE tight-junction integrity [43]. As LPS-activated
retinal microglia secrete prominent levels of chemokines and
inflammatory mediators [25,44], the effects that microglia co-culture
exert on RPE cells are likely mediated by chemokine signaling from
retinal microglia. Among these changes is the up-regulation of
cytokines that are strongly chemotactic for microglia, macrophages,
and monocytes, such as CCL2, CCL5, and SDF-1. These factors
likely contribute to the ability of co-culture RPE supernatants to
promote the in vitro migration of microglia cells, and to recruit
endogenous microglia in vivo to the subretinal space following
microglia transplantation. These observations raises the possibility of
a positive feedback mechanism by which early subretinal microglia
accumulation,throughinducedchangesinRPEgeneexpressionand
cytokine secretion, fosters a more pro-inflammatory and chemoat-
tractive environment in the subretinal space. The further recruit-
ment of microglia to the subretinal space, and their subsequent
activation in that locus, perpetuate a progressive accumulation of
microglia that incrementally abrogates the zone of immune privilege
in the subretinal space and advances AMD-relevant pathogenic
mechanisms at the retinochoroidal interface.
Our results showed that even though changes in RPE gene
expression were larger in co-cultures with activated microglia than
with unactivated microglia, the inductive effects of microglia
Figure 7. In vivo subretinal transplantation of retinal microglia
promotes choroidal neovascularization, RPE disorganization,
and microglia recruitment. The tissue effects of juxtaposing
microglia with RPE cells were assessed in an in vivo mouse model by
the injection of cultured microglia with factor-reduced Matrigel into the
subretinal space of adult, wild-type mice. Injected microglia, derived
from CX3CR1
+/GFP mice, were marked by GFP expression. Contralateral
eyes in experimental animals served as controls (injected with factor-
reduced Matrigel only without microglia). Four days after transplanta-
tion, mice were euthanized and perfused with DiI to mark vascular
structures. (A) Representative RPE flatmount from a control eye.
Arrowhead marks the injection entry site, and ellipse outlines the area
of the subretinal bleb formed. Little or no associated CNV (marked in
red by DiI perfusion) formation were observed in control eyes. (B)
Representative RPE flatmount from an eye injected with a subretinal
injection of Matrigel containing microglia (green). DiI perfusion reveals
presence of a feeding vessel (arrow) growing from the injection entry
site (arrowhead) to form a branching CNV complex that is centered at
the site of microglia cell accumulation. Scale bar (A, B)=300 mm (C)
Magnification of CNV complex (inset in B) showing location of the CNV
complex between the RPE and the overlying microglia in the subretinal
space (side panels). (D) Quantification of the area of CNV membranes
formed in control eyes versus eyes with subretinal microglia showed a
significant increased in CNV formation (n=10 animals, p,0.003, paired
t-test). (E–F) Phalloidin staining of F-actin in RPE flat-mounts in the area
of subretinal injection. The RPE layer in Matrigel controls demonstrated
a predominantly regular array of uniformly hexagonal cells with normal
cell-cell relations (E), while that in the area of subretinal microglia
transplantation showed pleomorphic and irregularly-spaced cells in
which the location of F-actin appeared disorganized (F). (G–H) Iba-1
staining of microglia in the outer retina (retinal flat-mounts, mounted
photoreceptor-side up) in control (G) and microglia-transplanted eyes
(H). The recruitment of endogenous microglia (labeled in red only) to
the outer retina was increased in the region of transplanted GFP+
microglia (green). (I) Migration of endogenous microglia (red) was
observed from the inner retina to the outer nuclear layer (ONL) and
subretinal space (SRS) (arrowheads) in the area of subretinal microglia
transplantation (green). Scale bars (E–I)=50 mm.
doi:10.1371/journal.pone.0007945.g007
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as in assays for microglial chemotaxis (Fig. 3D) and in vitro
angiogenesis (Fig. 6B). However, it is likely that in the context of
AMD, the displacement of retinal microglia to the subretinal space
may also bring microglia into contact with influences that may
serve to activate them. Retinal microglia observed in human AMD
specimens have amoeboid morphologies, suggesting their activated
status [19]. The initiating steps in this proposed model of
cumulative subretinal microglia accretion have not been defined
but may potentially be related to complement activation [45],
drusen accumulation [46], photoreceptor injury [47], or oxidative
stress in the outer retina [48]. Further studies on the regulatory
mechanisms underlying microglia distribution and migration
[24,49] in the retina, as well as their activation in the subretinal
space, may be useful in this respect.
Our results also indicated that retinal microglia co-culture
increased in RPE cells the expression and secretion of VEGF and
pro-angiogenic metalloproteinases, MMP1, MMP2, and MMP9.
Co-culture RPE supernatants were also effective in increasing
endothelial cell proliferation and migration as evaluated in 3
separate in vitro assays. These findings, together with an increase in
pro-inflammatory and chemoattractive factors, suggest that
microglial accumulation in the subretinal space may create a
pro-angiogenic environment that increases the likelihood of the
development of CNV. Metalloproteinases, thought to be capable
of comprising the natural barrier function of Bruch’s membrane to
CNV growth [50], have been previously related to the formation
of CNV in AMD and in animal models [51–54]. The growth of
CNV may be further encouraged by the increased secretion of
VEGF by RPE cells following co-culture that can directly
stimulate endothelial cell proliferation and migration [55]. In
support of the relationship betwen RPE alterations and CNV
formation, epidemiological studies have also linked the clinical
presence of RPE changes (scored as pigment abnormalities in the
fundus) occurring in patients with early and intermediate AMD
with an elevated 5-year risk for the development of CNV [10].
Our experiments with the in vivo transplantation of retinal
microglia demonstrated that the presence of subretinal microglia
exerts a strong pro-angiogenic influence in the formation and
growth of CNV. The creation of a pro-angiogenic environment in
the subretinal space, while mediated significantly by RPE
alterations, may also be contributed towards by the subretinal
microglia themselves. In our in vitro co-culture experiments, while
mRNA and protein analysis in RPE cell lysates relate directly to
RPE gene expression, protein analyses involving RPE co-culture
supernatants may however also contain contributions secreted
from retinal microglia cells. However, in our angiogenesis and
microglia-migration functional assays, we found that the changes
induced by RPE co-culture supernatants were significant when
compared not only to unexposed RPE supernatants, but also when
compared to supernatants of activated retinal microglia not
exposed to RPE cells (data not shown). As such, despite possible
contributions by retinal microglia themselves, changes in RPE
gene expression and protein secretion are likely play a prominent
role in inducing the structural and functional changes of
pathological significance in the subretinal space.
While our in vivo model system permits direct cell-cell contact
between retinalmicrogliaandRPE cells,thein vitrosystemused here
brings the two cell types in close proximity but however precludes
direct cellular surface contact. The similarities in the nature of
changes induced in both in vitro and in vivo systems (changes in RPE
structure, increased chemotaxis of microglia, pro-angiogenic effects)
suggest that many of these do not require direct microglial-RPE cell
contact, although additional studies may be required to investigate
the effects that result only from direct cellular contact. In additionto
retinal microglia-to-RPE communication, other forms of intercel-
lular interactions may also play a role in AMD pathogenesis. In
producing multiple cytokines, RPE cells are likely to reciprocally
affect physiology of subretinal microglia [56,57]. The close
anatomical proximity of drusen, which contain multiple immuno-
logically active molecules [58,59], may also contribute to other
pathologically relevant effects. Factors secreted or released from
photoreceptors [25] and Muller cells [60] in the vicinity may also
contribute. Future studies on the details of the interactions between
these cellular players converging in the subretinal space, and how
these are modulated by drusen components, can help elucidate
these cellular relationships further.
We also propose that the subretinal transplantation of cultured
retinal microglia employed here constitutes a useful animal model
for future study of intercellular and molecular interactions in this
locus. To the extent that retinal microglia-RPE interactions may
represent a potential therapeutic locus for intervention, this
transplantation model may be useful in the evaluation of potential
inhibitory agents [61]. Agents that successfully amelioriate the
structural changes in RPE cells and/or the growth of CNV
membranes into the subretinal space in this model may be
promising candidates for AMD therapy and prevention.
In summary, our results indicate that retinal microglia, when
placed in proximity to RPE cells, induce significant changes in 1)
the structure and distribution of RPE, and 2) expression and
secretion of multiple molecules from RPE cells that have
significant effects on the activation, recruitment, and retention of
immune cells and on angiogenesis. The in vivo presence of
subretinal microglia, simulated here by the subretinal transplan-
tation of cultured microglia, corroborate our in vitro findings,
promoting choroidal neovascularization, RPE disorganization,
and further microglia recruitment into the subretinal space. These
histological features, reminiscent of those found in both the early
and later exudative stages of AMD, suggest that the interaction
between microglia and RPE cells in the subretinal space may have
important relevance to the pathogenesis and progression of AMD.
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